Researchers have demonstrated that a protein called NEDD9 may be required for some of the most aggressive forms of breast cancer to grow. According to the researchers, the protein could serve as a clinical biomarker to indicate the presence of aggressive forms of breast cancer. NEDD9 may also provide a target for some future therapeutic against metastatic cancer.